Jay Mohr
The Wharton School
Tell me more about Jay Mohr?
Jay Mohr is an action-oriented and C-level executive with 37.8 years of experience in the biopharmaceutical industry. He has a strong track record of generating significant shareholder value by leading public and blue-chip venture-backed biotechnology companies. Jay is the Founding CEO of Gloucester Pharmaceuticals and Co-Founder of Locust Walk Partners. He has extensive experience in fundraising, investor relations, and product launch, with a focus on blockbuster pharmaceutical brands. Jay's specialties include CEO, COO, CBO, and CEO of various organizations. He is currently working as a General Partner in the General Management department.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Action-oriented, C-level executive with deep strategic leadership, transaction and commercial expertise in the biopharmaceutical industry. Track record of generating significant shareholder value by leading public and blue-chip venture-backed biotechnology companies. Founding CEO of Gloucester Pharmaceuticals and Co-Founder of Locust Walk Partners. Fundraising and investor relations expertise with venture capital, crossover institutional and family office groups. Significant product launch experience with responsibility for blockbuster pharmaceutical brands including responsibility for delivering topline and operating margin targets. Specialties: CEO, COO, CBO, Chief Executive Officer, Chief Business Officer, Chief Operating Officer, corporate development, board of directors, business development, fundraising, capital raising, financing, corporate finance, pharmaceuticals, biotechnology, biopharmaceuticals, life sciences, investor relations, communications, startups, cross-functional leadership, M&A, mergers, venture capital, licensing, due diligence, product management, product launch, change management, growth, team leadership, talent development, oncology, CNS, neurology, autoimmune disease, marketing strategy, P&L management, negotiations, private equity, PE
...See MoreWork Experience
Certified-Level Executive
Executive Vice President | Chief Business Officer
Chief Financial And Business Officer
Hospitals and Health Care
Jay Mohr's Professional Milestones
- Chief Operating and Business Officer | Head of Commercial Development: Driving strategic initiatives to optimize operations and achieve organizational goals.
- Chief Financial And Business Officer (2020-08-01~): Driving strategic financial planning and financial planning to optimize business performance and drive sustainable profitability.
Education
Marketing And Healthcare Management
1989-1991Skill
Strategy
Pharmaceutical Industry
Biotechnology
Mergers And Acquisitions
Venture Capital
Life Sciences
Lifesciences
Business Development
Biopharmaceuticals
Commercialization
Start Ups
Licensing
Strategic Planning
Corporate Development
Private Equity
Due Diligence
Clinical Development
P&l Management
Fda
Oncology
Product Marketing
Drug Development
Mergers
Partnering
Strategy Development
Angel Investing
Certification
Colleagues
Bruce Sachais
chief medical officer and vice president new york blood center enterprises
David Bench
Executive Vice President And Chief Financial Officer
David Klassen, CFA, MDiv
Chief Real Estate Officer
Christopher D. Hillyer, MD
President & Chief Executive Officer | Chief Scientific Officer | Rochester Blood Center General Partner | Cornell F Mitchell Research Institute | Cornell Ficknell Medical College
Larry Hannigan
cfo at new york blood center
Other Named Jay Mohr
Frequently asked questions
We found 5 Jay Mohr's email addresses
We found 2 Jay Mohr's phone numbers
Jay Mohr's social media include: Linkedin,
Jay Mohr works for New York Blood Center
Jay Mohr's role in New York Blood Center is Certified-Level Executive
Jay Mohr works in the industry of Hospitals and Health Care
Jay Mohr's colleagues are Bruce Sachais,David Bench,David Klassen, CFA, MDiv
Jay Mohr's latest job experience is Certified-Level Executive at New York Blood Center
Jay Mohr's latest education in The Wharton School